Literature DB >> 16766769

Fatal aseptic meningoencephalitis following infliximab treatment for inflammatory bowel disease.

R Quispel, H B van der Worp, M Pruissen, M E Schipper, B Oldenburg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16766769      PMCID： PMC1856322          DOI： 10.1136/gut.2006.093294

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  Infliximab-induced aseptic meningitis.

Authors:  H Marotte; J E Charrin; P Miossec
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

2.  Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum?

Authors:  Nikita Hegde; Charina Gayomali; Michael W Rich
Journal:  South Med J       Date:  2005-05       Impact factor: 0.954

3.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

4.  Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Authors:  N Mohan; E T Edwards; T R Cupps; P J Oliverio; G Sandberg; H Crayton; J R Richert; J N Siegel
Journal:  Arthritis Rheum       Date:  2001-12

5.  Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.

Authors:  Carlton W Thomas; Brian G Weinshenker; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2004-01       Impact factor: 5.325

6.  The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

Authors:  Jean-Frederic Colombel; Edward V Loftus; William J Tremaine; Laurence J Egan; W Scott Harmsen; Cathy D Schleck; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682
  6 in total
  5 in total

1.  Acute encephalomyelitis with multiple herpes viral reactivations during abatacept therapy.

Authors:  Hideto Nakajima; Ayami Takayama; Takumi Ito; Tetsushi Yoshikawa
Journal:  BMJ Case Rep       Date:  2013-05-09

2.  Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy.

Authors:  Alexander Winkelmann; Robert Patejdl; Sabine Wagner; Reiner Benecke; Uwe Klaus Zettl
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

3.  Infliximab-Induced Aseptic Meningitis in a Patient with Crohn's Disease.

Authors:  Zachary Junga; Brett Theeler; Manish Singla
Journal:  ACG Case Rep J       Date:  2018-06-20

4.  Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.

Authors:  Amy Kunchok; Allen J Aksamit; John M Davis; Orhun H Kantarci; B Mark Keegan; Sean J Pittock; Brian G Weinshenker; Andrew McKeon
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

5.  Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report.

Authors:  Matthew J Booker; Julia Flint; Shanmugam Saravana
Journal:  Cases J       Date:  2008-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.